Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo

AIDS Research and Human Retroviruses

Volumn 26, Issue 7, 2010, Pages 815-820

  Carrera, Cristina ^a   Pinilla, Milagros ^a   Pérez Álvarez, Lucía ^a   Thomson, Michael M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; ISOPROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VPR PROTEIN; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; EXON; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA SPLICING; CELL CULTURE; DNA SEQUENCE; GENE EXPRESSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

CELLS, CULTURED; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77954922971     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0011     Document Type: Article

References (22)

1. Schwartz S, Felber BK, Benko DM, Fenyo EM, and Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990;64:2519-2529.
2. Purcell DF and Martin M: Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993; 67:6365-6378.
3. Mary C, Telles JN, Cheynet V, et al.: Quantitative and dis-cirminative detection of individual HIV-1 mRNA subspecies by an RNase mapping assay. J Virol Methods 1994;49:9-24.
4. Saltarelli MJ, Hadziyannis E, Hart CE, et al.: Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals. AIDS Res Hum Retroviruses 1996;12:1443-1456.
5. Neumann M, Harrison J, Saltarelli MJ, et al.: Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res Human Retroviruses 1994;19:1531-1542.
6. Benko DM, Schwartz S, Pavlakis GN, and Felber BK: A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol 1990;64:2505-2518.
7. Salfeld J, Göttlinger HG, Sia RA, Park RE, Sodroski JG, and Haseltine WA: A tripartite HIV-1 tat-env-rev fusion protein. EMBO J 1990;9:965-970.
8. Berkhout B and van Wamel JLB: Identification of a novel splice acceptor in the HIV-1 genome: Independent expression of the cytoplasmic tail of the envelope protein. Arch Virol 1996;141:839-855.
9. Lü tzelberger M, Reinert LS, Das AT, Berkhout B, and Kjems J: A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability. J Biol Chem 2006;281: 18644-18651.
10. Smith J, Azad J, and Deacon N: Identification of two novel human immunodeficiency splice acceptor sites in infected T cell lines. J Gen Virol 1992;73:1825-1828.
11. Furtado MR, Balachandran R, Gupta P, and Wolinski SM: Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel Tat-Env fusion protein. Virology 1991;185:258-270.
12. O'Reilly MM., McNally MT, and Beemon KL: Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 1995;213:373-385.
13. Madsen JM and Stoltzfus CM: A suboptimal 5' splice site downstream of HIV-1 splice site is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology 2009;3:10-19.
14. Stoltzfus CM: Regulation of HIV-1 alternative splicing and its role in virus replication. Adv Virus Res 2009;74:1-40.
15. Riggs NL, Little SJ, Richman DD, and Guatelli JC: Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors. Virology 1994;202:264-271.
16. Wentz MP, Moore BE, Cloyd MW, Berget SM, and Done-hower LA: A naturally arising mutation of a potential silencer exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. J Virol 1997;71:8542-8551.
17. HIV Sequence Database: Los Alamos National Laboratory. Accessible at http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html.
18. Robert-Guroff M, Popovic M, Gartner S, et al.: Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 1990;64:3391-3398.
19. Michael NL, Vahey MT, D'Arcy L, et al.: Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol 1994;68:979-987.
20. Vanhée-Brossollet C, Thoreau H, Serpente N, D'Auriol L, Lévy JP, and Vaquero C: A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV\+ individuals. Virology 1995;206:196-202.
21. Landry S, Malim M, Lefort S, et al.: Detection, characterization and regulation of antisense transcripts in HIV-1. Ret-rovirology 2007;4:71.
22. Caudevilla C, Da Silva-Azevedo L, Berg B, Guhl E, Graess-man M, and Graessman A: Heterologous HIV-nef mRNA trans-splicing: A new principle how mammalian cells generate hybrid mRNA and protein molecules. FEBS Lett 2001;507:269-279.